California Public Employees Retirement System’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-54,226
| Closed | -$1.43M | – | 1268 |
|
2021
Q4 | $1.43M | Sell |
54,226
-2,229
| -4% | -$58.8K | ﹤0.01% | 1217 |
|
2021
Q3 | $5.68M | Hold |
56,455
| – | – | ﹤0.01% | 1178 |
|
2021
Q2 | $7.99M | Sell |
56,455
-34,468
| -38% | -$4.88M | 0.01% | 1130 |
|
2021
Q1 | $9.07M | Buy |
90,923
+39,492
| +77% | +$3.94M | 0.01% | 1133 |
|
2020
Q4 | $6.36M | Buy |
51,431
+947
| +2% | +$117K | ﹤0.01% | 1282 |
|
2020
Q3 | $4.92M | Sell |
50,484
-2,597
| -5% | -$253K | ﹤0.01% | 1244 |
|
2020
Q2 | $8.28M | Buy |
53,081
+2,504
| +5% | +$391K | 0.01% | 912 |
|
2020
Q1 | $7.3M | Sell |
50,577
-19,970
| -28% | -$2.88M | 0.01% | 826 |
|
2019
Q4 | $14.4M | Buy |
70,547
+33,428
| +90% | +$6.83M | 0.01% | 743 |
|
2019
Q3 | $2.98M | Buy |
37,119
+4,384
| +13% | +$352K | ﹤0.01% | 1633 |
|
2019
Q2 | $3.09M | Sell |
32,735
-266
| -0.8% | -$25.1K | ﹤0.01% | 1418 |
|
2019
Q1 | $2.82M | Buy |
33,001
+4,498
| +16% | +$384K | ﹤0.01% | 1551 |
|
2018
Q4 | $1.6M | Buy |
28,503
+25,000
| +714% | +$1.4M | ﹤0.01% | 1875 |
|
2018
Q3 | $286K | Buy |
+3,503
| New | +$286K | ﹤0.01% | 2897 |
|